We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Novartis AG | NYSE:NVS | NYSE | Depository Receipt |
Price Change | % Change | Price | |
---|---|---|---|
2.60 | 2.74% | 97.722 |
High Price | Low Price | Open Price | Traded | Last Trade |
---|---|---|---|---|
99.50 | 97.0305 | 98.74 | 3,837,384 | 23:30:36 |
Date | Time | Source | Headline |
---|---|---|---|
22/1/2024 | 06:59 | DJN | Sandoz to Acquire Cimerli Business from Coherus for $170 Million |
11/1/2024 | 18:02 | DJN | Cytokinetics Shares Slide as Novartis Reportedly Shies Away From Deal |
08/1/2024 | 18:43 | DJN | Cytokinetics Shares Jump 16% After WSJ Report of Novartis Deal |
08/1/2024 | 15:41 | DJN | Novartis on Track for Record High Close -- Data Talk |
08/1/2024 | 07:01 | DJN | Novartis's Scemblix Drug Meets Main Goals in Late-Stage Leukemia Trial |
05/1/2024 | 15:15 | DJN | Novartis to Make Pluvicto Radioligand Therapy at Indianapolis Plant |
02/1/2024 | 12:46 | DJN | Voyager Therapeutics Shares Leap Premarket on Novartis Collaboration |
11/12/2023 | 07:02 | DJN | Novartis Drug Meets Primary Goal in Late-Stage Study for Kidney Disease |
06/12/2023 | 10:14 | DJN | Merck Shares Slump After Multiple Sclerosis Drug Fails in Late-Stage Trials |
28/11/2023 | 20:08 | DJN | FDA Looking Into All Approved CAR T Therapies on Risk of Cancer in White.. |
1 Year Novartis Chart |
Intraday Novartis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions